Pendal Group LTD Abb Vie Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $371,711 - $472,566	2,701 Added 147.35%	4,534 $695,000
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $66,253 - $82,202	-502 Reduced 21.5%	1,833 $297,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $250,849 - $317,396	2,335 New	2,335 $316,000
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $1.73 Million - $1.92 Million	-16,404 Closed	0 $0
Q1 2021 May 24, 2021	BUY	$102.3 - $112.62 $1.68 Million - $1.85 Million	16,404 New	16,404 $1.78 Million
Q1 2021 May 03, 2021	SELL	$102.3 - $112.62 $1.28 Million - $1.41 Million	-12,550 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $1.66 Million - $2.24 Million	-20,625 Reduced 62.17%	12,550 $1.35 Million
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $4.82 Million - $5.66 Million	-56,134 Reduced 62.85%	33,175 $2.91 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $6.01 Million - $8.04 Million	81,879 Added 1102.01%	89,309 $8.77 Million
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $479,235 - $726,579	7,430 New	7,430 $566,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $5.16 Million - $6.2 Million	-81,903 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$65.7 - $83.98 $4.13 Million - $5.28 Million	-62,874 Reduced 43.43%	81,903 $0
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $10.1 Million - $11.9 Million	131,278 Added 972.5%	144,777 $0
Q4 2018 Jan 30, 2019	SELL	$77.85 - $96.01 $2.66 Million - $3.28 Million	-34,207 Reduced 71.7%	13,499 $1.24 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $2.41 Million - $2.68 Million	-27,135 Reduced 36.26%	47,706 $0
Q2 2018 Jul 18, 2018	SELL	$89.78 - $106.23 $1.77 Million - $2.1 Million	-19,722 Reduced 20.86%	74,841 $0
Q1 2018 May 08, 2018	BUY	$92.01 - $123.21 $95,322 - $127,645	1,036 Added 1.11%	94,563 $0
Q4 2017 Feb 06, 2018	SELL	$89.56 - $98.21 $2.12 Million - $2.32 Million	-23,621 Reduced 20.16%	93,527 $0
Q3 2017 Nov 01, 2017	BUY	$69.85 - $89.22 $8.18 Million - $10.5 Million	117,148	117,148 $0

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$34.2 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$27.4 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.6 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$10.4 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.74 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account